title: ESOT update on immunosuppressive substances in clinical development or use 1995.
abstract: The ESOT Council conducted an inquiry on new immunosuppressive substances in order to help keep members of ESOT informed. Thirty-one pharmaceutical companies were sent a questionnaire indicating whether they were developing new immunosuppressive substances/antibodies. Sixteen companies responded: 11 furnished information on 16 substances; 5 said that they were not developing any new immunosuppressive agents. Fifteen companies did not reply at all. The results of the first inquiry are reported here.
authors.affiliation: Division of Nephrology, Kantonsspital Basel, Switzerland.
authors.forename: G
authors.initials: G
authors.lastname: Thiel
mesh_terms: D004345:Drug Industry; D005060:Europe; D006801:Humans; D007166:Immunosuppressive Agents / Q000592:standards; D012955:Societies, Medical; D011795:Surveys and Questionnaires; D014181:Transplantation Immunology
chemical_list: D007166:Immunosuppressive Agents